Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25911951 | 0.74 | LCK (0.41) | TSHR | |
| SCHEMBL19233744 | 0.70 | MAPT (0.33) | KDM4ENPC1ALDH1A1TP53HPGD | |
| SCHEMBL19233701 | 0.70 | EPHB4 (0.33) | KDM4ENPC1ALDH1A1TP53HPGD | |
| SCHEMBL25919048 | 0.69 | POLB (0.32) | KDM4EALDH1A1RAB9ASMN1; SMN2 | |
| SCHEMBL25911950 | 0.67 | NOS3 (0.37) | — | |
| SCHEMBL19233745 | 0.67 | ALKBH5 (0.33) | KDM4ENPC1ALDH1A1TP53HPGD | |
| SCHEMBL19233703 | 0.67 | ALKBH5 (0.33) | KDM4ENPC1ALDH1A1TP53HPGD | |
| SCHEMBL25919142 | 0.67 | ALKBH5 (0.40) | KDM4EALDH1A1HPGDNPSR1HSD17B10 | |
| SCHEMBL25912253 | 0.66 | ALDH1A1 (0.35) | KDM4ENPC1ALDH1A1TP53HPGD | |
| SCHEMBL25912225 | 0.65 | GRM5 (0.33) | KDM4EALDH1A1HPGDSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11716898-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-08-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11716898-B2 | Organic electroluminescent materials and devices | OCIAD2, OCIAD1, JUND | KDM4E 2637/4885NPC1 2138/4885ALDH1A1 2423/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.